Respiratory Disease Vaccine Market by Infection (Influenza Virus, Pertussis, Streptococcus Pneumoniae), Type (Bacterial Vaccine, Combination Vaccine, Viral Vaccine), Age Group - Global Forecast 2024-2030

Respiratory Disease Vaccine Market by Infection (Influenza Virus, Pertussis, Streptococcus Pneumoniae), Type (Bacterial Vaccine, Combination Vaccine, Viral Vaccine), Age Group - Global Forecast 2024-2030


The Respiratory Disease Vaccine Market size was estimated at USD 23.42 billion in 2023 and expected to reach USD 24.78 billion in 2024, at a CAGR 5.87% to reach USD 34.93 billion by 2030.

Global Respiratory Disease Vaccine Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Respiratory Disease Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Respiratory Disease Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Disease Vaccine Market, highlighting leading vendors and their innovative profiles. These include Astrazeneca PLC, Bavarian Nordic A/S, Bharat Biotech International Ltd., CanSino Biologics Inc., Emergent BioSolutions, Inc., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Moderna, Inc., Pfizer Inc., Sanofi S.A., Seqirus USA Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., and Vaxine Pty Ltd..

Market Segmentation & Coverage



This research report categorizes the Respiratory Disease Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Infection
Influenza Virus
Pertussis
Streptococcus Pneumoniae
Tuberculosis
Type
Bacterial Vaccine
Combination Vaccine
Viral Vaccine
Age Group
Adolescent Vaccination
Adult Vaccination
Infant Vaccination
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Respiratory Disease Vaccine Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Respiratory Disease Vaccine Market?
3. What are the technology trends and regulatory frameworks in the Respiratory Disease Vaccine Market?
4. What is the market share of the leading vendors in the Respiratory Disease Vaccine Market?
5. Which modes and strategic moves are suitable for entering the Respiratory Disease Vaccine Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Respiratory Disease Vaccine Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of respiratory disorders
5.1.1.2. Clinical trials and vaccines developments in pipeline
5.1.1.3. Government initiatives supporting respiratory health
5.1.2. Restraints
5.1.2.1. Lack of inadequate delivery infrastructure & limited awareness
5.1.3. Opportunities
5.1.3.1. Increasing R&D expenditure by leading companies
5.1.3.2. Increase vaccine availability through reselling collaborations
5.1.4. Challenges
5.1.4.1. Consumer trust & confidence in respiratory disease vaccination
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Respiratory Disease Vaccine Market, by Infection
6.1. Introduction
6.2. Influenza Virus
6.3. Pertussis
6.4. Streptococcus Pneumoniae
6.5. Tuberculosis
7. Respiratory Disease Vaccine Market, by Type
7.1. Introduction
7.2. Bacterial Vaccine
7.3. Combination Vaccine
7.4. Viral Vaccine
8. Respiratory Disease Vaccine Market, by Age Group
8.1. Introduction
8.2. Adolescent Vaccination
8.3. Adult Vaccination
8.4. Infant Vaccination
9. Americas Respiratory Disease Vaccine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Respiratory Disease Vaccine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Respiratory Disease Vaccine Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Astrazeneca PLC
13.1.2. Bavarian Nordic A/S
13.1.3. Bharat Biotech International Ltd.
13.1.4. CanSino Biologics Inc.
13.1.5. Emergent BioSolutions, Inc.
13.1.6. GlaxoSmithKline PLC
13.1.7. Johnson & Johnson Services, Inc.
13.1.8. Merck & Co., Inc.
13.1.9. Moderna, Inc.
13.1.10. Pfizer Inc.
13.1.11. Sanofi S.A.
13.1.12. Seqirus USA Inc.
13.1.13. Serum Institute of India Pvt. Ltd.
13.1.14. Sinovac Biotech Ltd.
13.1.15. Vaxine Pty Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. RESPIRATORY DISEASE VACCINE MARKET RESEARCH PROCESS
FIGURE 2. RESPIRATORY DISEASE VACCINE MARKET SIZE, 2023 VS 2030
FIGURE 3. RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RESPIRATORY DISEASE VACCINE MARKET DYNAMICS
FIGURE 7. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2023 VS 2030 (%)
FIGURE 8. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 12. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. RESPIRATORY DISEASE VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. RESPIRATORY DISEASE VACCINE MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings